Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Elysium Health™ Announces the Launch of VISION™ for Eye Longevity, Performance, and Protection

Working with the world's leading scientists and clinicians, Elysium Health's™ mission is to to improve human healthspan and lifespan by providing direct access to breakthroughs in longevity science. Learn more at elysiumhealth.com. (PRNewsfoto/Elysium Health)

News provided by

Elysium Health

Oct 16, 2024, 08:15 ET

Share this article

Share toX

Share this article

Share toX

Developed with the guidance of Stanford University ophthalmologist and researcher Dr. Theodore Leng, VISION supports visual performance and eye health at every stage of life

NEW YORK, Oct. 16, 2024 /PRNewswire/ -- Elysium Health, Inc.™, a leading longevity science company, today announced the launch of VISION™ by Elysium Health for eye longevity, performance, and protection. Developed with the guidance of Theodore Leng, M.D., leading retinal specialist, ophthalmologist, and Director of Clinical and Translational Research at the Byers Eye Institute at Stanford University School of Medicine, Vision is specifically formulated to support visual performance and eye health at every stage of life. Vision leverages the latest research on xanthophyll carotenoids—plant pigments that accumulate in the eye and provide powerful antioxidant defense and photoprotection—with Elysium Health's Protective Intervention for Xanthin-based Eye Longevity (PIXEL) Complex™.

Continue Reading
Developed with the guidance of Theodore Leng, M.D., leading retinal specialist, ophthalmologist, and Director of Clinical and Translational Research at the Byers Eye Institute at Stanford University School of Medicine, Vision by Elysium Health is specifically formulated to support visual performance and eye health at every stage of life.
Developed with the guidance of Theodore Leng, M.D., leading retinal specialist, ophthalmologist, and Director of Clinical and Translational Research at the Byers Eye Institute at Stanford University School of Medicine, Vision by Elysium Health is specifically formulated to support visual performance and eye health at every stage of life.
Supplementation with all three macular carotenoids (M+Z+L) in Vision by Elysium Health resulted in a significant increase in macular pigment density compared to supplementation with Z+L (provided by AREDS 2) or placebo. *P < 0.05. Adapted from Loughman et al., 2012
Supplementation with all three macular carotenoids (M+Z+L) in Vision by Elysium Health resulted in a significant increase in macular pigment density compared to supplementation with Z+L (provided by AREDS 2) or placebo. *P < 0.05. Adapted from Loughman et al., 2012

Vision's novel formulation:

  • Enhances visual performance by increasing contrast sensitivity
  • Filters high-energy blue light and protects the eyes from oxidative stress
  • Targets the age-related loss in macular pigment density to support long-term eye and vision health

"There is no better formulation than Vision for eye health—leveraging 20 years of data behind the AREDS studies (the National Eye Institute's major clinical trials on age-related eye diseases) and the latest breakthroughs in xanthophyll research," said Dr. Leng.

Everyday life—from constant exposure to high-energy blue light to aging, pollution, and intrinsic metabolic activities—makes the eyes especially vulnerable to oxidative stress that can lead to cellular damage and impact eye health and visual performance. The three macular carotenoids in Vision protect light-detecting cells in the back of the eyes by filtering high-energy blue light and neutralizing free radicals. They also reduce image blur and glare and improve fine detail distinction and contrast enhancement, critical for daily tasks like reading, writing, and driving, as well as performance-oriented activities, including golf, tennis, pickleball, basketball, snow sports, and water sports. With age, levels of these critical pigments decline, contributing to deterioration in eye health and visual performance. Macular degeneration is the most common cause of vision decline among individuals 60 and over.

AREDS 2 is a well-established formula extensively studied by the National Eye Institute for long-term macular support, but it contains just two of the three macular carotenoids. Supplementation with the two macular carotenoids in AREDS 2 results in only a delayed, modest increase in macular pigment density. In contrast, Elysium Health's Vision provides all three macular carotenoids in a specific formulation that is clinically proven to rapidly and significantly increase macular pigment density, and support visual performance and eye health throughout life. In addition to the three macular carotenoids, the PIXEL Complex in Vision includes a fourth xanthophyll carotenoid, astaxanthin, a powerful antioxidant that is clinically proven to increase blood flow to the retina to support the delivery of nutrients and oxygen and support the eyes during extended screen use.

"In the early stages of developing Vision, I, like many people, believed eye health centered around older ages and loss of eyesight," said Elysium Health CEO Eric Marcotulli. "And while maintaining eye health and visual performance is certainly a concern as we get older, I learned that people at any age can benefit from improved contrast sensitivity and the filtering of high-energy blue light, which bombards our eyes every day. We have been privileged to collaborate with Dr. Leng to develop another breakthrough product with Vision, which directly reinforces the highly specialized ways that our eyes have evolved to utilize natural compounds to support performance."

About Elysium Health™
Working with the world's leading scientists and clinicians, Elysium Health's™ mission is to improve human healthspan and lifespan by providing direct access to breakthroughs in longevity science. Learn more at elysiumhealth.com.

SOURCE Elysium Health

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Elysium Health™ Announces the Launch of COFACTOR™: An advanced 4-in-1 Collagen System With NAD+ Boost

Elysium Health™ Announces the Launch of COFACTOR™: An advanced 4-in-1 Collagen System With NAD+ Boost

Elysium Health, Inc.™, a leading life sciences company focused on aging research, today announced the launch of COFACTOR™ by Elysium Health, a...

New Research by Elysium Health and University of Oxford Reveals Link Between Naturally Occurring Amino Acid and Accelerated Aging

New Research by Elysium Health and University of Oxford Reveals Link Between Naturally Occurring Amino Acid and Accelerated Aging

A research collaboration between Elysium Health, Inc.™, a leading longevity science company, and the University of Oxford recently demonstrated in a...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.